Mucinex Maker Sues To Maintain Market

Law360, New York (October 2, 2006, 12:00 AM EDT) -- Adams Respiratory Therapeutics Inc. filed a patent infringement suit Monday in federal court in New Jersey, seeking to protect the market for its best-selling anti-congestion drugs.

The New Jersey-based company filed the lawsuit against Mutual Pharmaceuticals Co., United Research Laboratories Inc. and their parent company, Pharmaceutical Holdings Corp.

The suit comes just after the defendants filed an Abbreviated New Drug Application seeking U.S. Food and Drug Administration approval to make and sell extended-release guaifenesin tablets.

The plaintiff claims that the defendants’ bid to market generic guaifenesin...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.